SCHEMBL7155206

SCHEMBL7155206

OB(O)CCCCCn1cnc2cncnc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 1/20 0.47
▸ LTA4H P09960 1/20 0.43
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ ADORA2A P29274 3/20 0.35
▸ ADCY5 O95622 3/20 0.34
▸ CYP1A2 P05177 3/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ CYP2C9 P11712 2/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HBB P68871 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8464130 0.84 FDPS (0.50) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL8649807 0.81 FDPS (0.47) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL8656700 0.79 FDPS (0.48) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL3691691 0.79 FDPS (0.48) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL8088086 0.79 FDPS (0.48) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL27589863 0.79 FDPS (0.49) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL11904868 0.79 FDPS (0.49) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL5017550 0.79 FDPS (0.50) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL6950642 0.77 ADORA2A (0.53) FDPSLTA4HHDAC1HDAC6ADORA2A
SCHEMBL5017009 0.77 FDPS (0.49) FDPSLTA4HHDAC1HDAC6ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030022864-A1 9-[(5-dihydroxyboryl)-pentyl] purines, useful as an inhibitor of inflammatory cytokines LEUKOMED, INC. 2003-01-30 — — US disclosed
US-20030022864-A1 9-[(5-dihydroxyboryl)-pentyl] purines, useful as an inhibitor of inflammatory cytokines LEUKOMED, INC. 2003-01-30 — — US disclosed
WO-2002085916-A1 9-[(5-DIHYDROXYBORYL)-PENTYL] PURINES, INHIBITOR OF INFLAMMATORY CYTOKINES UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2002-10-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022864-A1 9-[(5-dihydroxyboryl)-pentyl] purines, useful as an inhibitor of inflammatory cytokines IL1B, IL1A, IL1R1 FDPS 222/4885LTA4H 638/4885HDAC1 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback